Stockreport

Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29

Paysign, Inc.  (PAYS) 
PDF BOSTON--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking se [Read more]